Last reviewed · How we verify
NCT03749512
NLCR in Prediction of the Grade of Lung Tumor.
trial testing Complete blood count in Lung Neoplasm in 400 participants. Completed in 16 November 2018.
15 October 2018
Quick facts
| Lead sponsor | Medical University of Silesia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 400 |
| Start date | 1 October 2014 |
| Primary completion | 15 October 2018 |
| Estimated completion | 16 November 2018 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Complete blood count
- Histopathological examination
Conditions studied
- Lung Neoplasm — all drugs for Lung Neoplasm →
Sponsor
Medical University of Silesia
Who can join
18 and older, any sex, with Lung Neoplasm. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to assess whether the value of neutrophil-lymphocyte count ratio from the routine preoperative blood test may predict lung tumors' grading.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03749512
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Complete blood count
Trials testing the same drug.
- NCT06387667 — Characterizing Diversity and Antifungal Resistance in Immunocompromised ICU Patients With Respiratory Tract Infections · NA · not yet recruiting
- NCT07149883 — Evaluation of Mean Platelet Volume and Systemic Inflammatory Response Index (SIRI) in Patients of Acute Coronary Syndrom · not yet recruiting
- NCT06632041 — Necrotizing Enterocolities · not yet recruiting
- NCT06413563 — Analysis of Peripheral Blood Lymphocytes in Patients With Juvenile Idiopathic Arthritis With Respect to Disease Subtypes · not yet recruiting
- NCT05874141 — Comorbidities in Type 2 Diabetes Mellitus · NA · recruiting
Other recruiting trials for Lung Neoplasm
Currently open trials in the same condition.
- NCT06780098 — Substudy 01I: A Study of Investigational Agents in Participants With Previously Treated Stage IV Squamous Non-small Cell · Phase 2 · recruiting
- NCT06638398 — Biomarker Platform (Virtual Nodule Clinic) for the Management of Indeterminate Pulmonary Nodules · NA · active not recruiting
- NCT06158971 — Feasibility Study of the Microwave Ablation System for Lung Tissue Ablation · NA · recruiting
- NCT06254196 — Clinical Trial of Telenursing for Monitoring Supportive Care Needs in Patients With Lung Cancer and Melanoma Candidates · NA · recruiting
- NCT06419114 — Exploration of Optical Coherence Tomography-Guided Transbronchial Biopsy in Peripheral Pulmonary Lesions · recruiting
Other Medical University of Silesia trials
Trials by the same sponsor.
- NCT06212674 — Single-stage Pulmonary Vein Isolation Combined With Percutaneous Left Atrial Appendage Occluder Implantation in Patients · Phase 4 · recruiting
- NCT06970002 — Respiratory Stabilization in Chronic Acidosis Before Bronchofiberoscopy & Non-Invasive Ventilation Effectivenes · NA · not yet recruiting
- NCT07137299 — POPQ Associated With Total Laparoscopic Hysterectomy · not yet recruiting
- NCT06970041 — To Assess the Types of Mechanical Ventilation in Enabling Therapeutic Bronchofiberoscopy in Patients With Decompensated · NA · not yet recruiting
- NCT07120529 — Minimally Invasive Surgery Versus Open Radical Hysterectomy in Presumably Early Stage Cervical Cancer: a Retrospective M · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03749512 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Medical University of Silesia
- Last refreshed: 21 November 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03749512.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing